AmorChem l.p.

32 articles with AmorChem l.p.

• Amorchem Selected for Investment by the Venture Capital Catalyst Initiative

  11/6/2018

  AmorChem was built through the vision and leadership of its two founders, Elizabeth Douville and Inès Holzbaur, making it one of the rare venture capital funds led by two women.

• 

  BioSpace Movers and Shakers Nov. 5

  11/5/2018

  Biopharma companies make key appointments to fill leadership positions. Let's take a look!

• AmorChem Announces the Composition of Its Scientific Advisory Committee

  3/2/2018

  AmorChem selected these highly qualified individuals because collectively, they offer an enviable array of diversified expertise and experience in lifesciences venture capital investment, drug discovery and pharmaceutical development.

• AmorChem l.p. Release: Company Spins Out Its SEMA 3A Technology Into Semathera, With 1M$ Seed Investment

  1/11/2017

• AmorChem l.p. Spins Out Its Usp15-Deubiquitinylation (Dub) Drug Discovery Platform Into Corbin Therapeutics, With A First 1M$ Seed Investment

  1/9/2017

• AmorChem l.p. Spins Out Its CD36 Technology Into Mperia Therapeutics, With 1M$ Series A Investment

  9/12/2016

• AmorChem l.p. Release: André-Dupont Prize Awarded To Mike Sapieha!

  10/6/2015

• AmorChem l.p. Invests In Projects At The Personalized Cancer Immunotherapy Program

  4/8/2015

• AmorChem l.p., Université Laval And CHU De Québec Collaborate On The Development Of A Treatment For Friedreich’s Ataxia

  8/4/2014

• Roche And AmorChem l.p. Announce Alliance Focused On Myotonic Muscular Dystrophy 1

  7/29/2014

• AmorChem l.p. Invests In A Novel Drug For Atherosclerosis.

  7/23/2014

• AmorChem l.p. Invests In A Diabetic Macular Edema Opportunity

  6/18/2014

• AmorChem l.p. Aims At Two Major Respiratory Diseases With A Single CFTR Strategy

  6/18/2014

• BELLUS Health And AmorChem l.p. Announce A Partnership To Develop Drug Candidates For AL Amyloidosis

  12/19/2013

• AmorChem l.p., Universite Laval And CHU De Quebec Collaborate On The Development Of A Treatment For Endometriosis And Estrogen-Dependent Cancers

  12/19/2013

• AmorChem l.p.'s KNOCK-OUT™ Event: We Have A Champion!

  12/19/2013

• AmorChem l.p. Invests In The Discovery Of A Novel Cholesterol - Lowering Drug Targeting PCSK9

  12/19/2013

• AmorChem l.p. Invests In New DUB Target For Neuro-Inflammation

  12/19/2013

• AmorChem l.p. Invests In A Novel Titanium Porous Compression Screw For Bone Fixation And Puts In Place A Master Agreement With McGill University

  12/19/2013

• AmorChem l.p. Invests In A Novel Drug For Geographic Atrophy

  12/19/2013